Bluebird bio Inc (NASDAQ: BLUE) on Tuesday, plunged -3.63% from the previous trading day, before settling in for the closing price of $0.41. Within the past 52 weeks, BLUE’s price has moved between $0.34 and $5.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 120.02% over the past five years. The company achieved an average annual earnings per share of 20.29%. With a float of $192.36 million, this company’s outstanding shares have now reached $192.77 million.
Let’s look at the performance matrix of the company that is accounted for 375 employees. In terms of profitability, gross margin is -37.34%, operating margin of -609.26%, and the pretax margin is -567.34%.
Bluebird bio Inc (BLUE) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Bluebird bio Inc is 0.80%, while institutional ownership is 42.39%. The most recent insider transaction that took place on Sep 30 ’24, was worth 529. In this transaction an insider of this company sold 1,006 shares at a rate of $0.53, taking the stock ownership to the 170,000 shares. Before that another transaction happened on Sep 30 ’24, when Company’s President and CEO sold 34,780 for $0.53, making the entire transaction worth $18,270. This insider now owns 375,218 shares in total.
Bluebird bio Inc (BLUE) Performance Highlights and Predictions
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.66 earnings per share (EPS) for the period topping the consensus outlook (set at -0.67) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.80% during the next five years compared to 28.98% growth over the previous five years of trading.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
Bluebird bio Inc (BLUE) is currently performing well based on its current performance indicators. A quick ratio of 0.57 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.14, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of Bluebird bio Inc (BLUE)
Bluebird bio Inc (NASDAQ: BLUE) saw its 5-day average volume 8.45 million, a positive change from its year-to-date volume of 7.45 million. As of the previous 9 days, the stock’s Stochastic %D was 38.49%. Additionally, its Average True Range was 0.04.
During the past 100 days, Bluebird bio Inc’s (BLUE) raw stochastic average was set at 4.88%, which indicates a significant decrease from 29.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.97% in the past 14 days, which was lower than the 96.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4976, while its 200-day Moving Average is $0.9208. Nevertheless, the first resistance level for the watch stands at $0.4168 in the near term. At $0.4430, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4564. If the price goes on to break the first support level at $0.3772, it is likely to go to the next support level at $0.3638. Assuming the price breaks the second support level, the third support level stands at $0.3376.
Bluebird bio Inc (NASDAQ: BLUE) Key Stats
Market capitalization of the company is 75.74 million based on 193,914K outstanding shares. Right now, sales total 29,500 K and income totals -211,910 K. The company made 16,100 K in profit during its latest quarter, and -81,390 K in sales during its previous quarter.
